Department of Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University, Fukuyama 729-0292, Japan.
Brain Res. 2012 Apr 11;1448:63-70. doi: 10.1016/j.brainres.2012.02.004. Epub 2012 Feb 9.
We have shown previously that intracerebroventricular (icv) injection of naloxone (a non-selective opioid receptor antagonist) or naloxonazine (a selective μ1-opioid receptor antagonist) at the maintenance phase of hibernation arouses Syrian hamsters from hibernation. This study was designed to clarify the role of β-endorphin (an endogenous μ-opioid receptor ligand) on regulation of body temperature (T(b)) during the maintenance phase of hibernation. The number of c-Fos-positive cells and β-endorphin-like immunoreactivity increased in the arcuate nucleus (ARC) after hibernation onset. In contrast, endomorphin-1 (an endogenous μ-opioid receptor ligand)-like immunoreactivity observed on the anterior hypothalamus decreased after hibernation onset. In addition, hibernation was interrupted by icv injection of anti-β-endorphin antiserum at the maintenance phase of hibernation. The mRNA expression level of proopiomelanocortin (a precursor of β-endorphin) on ARC did not change throughout the hibernation phase. However, the mRNA expression level of prohormone convertase-1 increased after hibernation onset. [D-Ala2,N-MePhe4,Gly-ol5] enkephalin (DAMGO, a selective μ-opioid receptor agonist) microinjection into the dorsomedial hypothalamus (DMH) elicited the most marked T(b) decrease than other sites such as the preoptic area (PO), anterior hypothalamus (AH), lateral hypothalamus (LH), ventromedial hypothalamus and posterior hypothalamus (PH). However, microinjected DAMGO into the medial septum indicated negligible changes in T(b). These results suggest that β-endorphin which synthesizes in ARC neurons regulates T(b) during the maintenance phase of hibernation by activating μ-opioid receptors in PO, AH, VMH, DMH and PH.
我们之前已经表明,在冬眠维持阶段向脑室内(icv)注射纳洛酮(一种非选择性阿片受体拮抗剂)或纳洛酮嗪(一种选择性 μ1-阿片受体拮抗剂)可以使叙利亚仓鼠从冬眠中苏醒。这项研究旨在阐明β-内啡肽(一种内源性 μ 阿片受体配体)在冬眠维持阶段调节体温(T(b))中的作用。冬眠开始后,弓状核(ARC)中的 c-Fos 阳性细胞和 β-内啡肽样免疫反应增加。相比之下,冬眠开始后,前下丘脑的内吗啡肽-1(一种内源性 μ 阿片受体配体)样免疫反应减少。此外,在冬眠维持阶段向脑室内注射抗β-内啡肽抗血清会中断冬眠。ARC 上的 proopiomelanocortin(β-内啡肽的前体)的 mRNA 表达水平在整个冬眠阶段没有变化。然而,冬眠开始后,前激素转化酶-1 的 mRNA 表达水平增加。[D-Ala2,N-MePhe4,Gly-ol5]脑啡肽(DAMGO,一种选择性 μ 阿片受体激动剂)注射到背内侧下丘脑(DMH)会引起最显著的体温下降,比其他部位如视前区(PO)、前下丘脑(AH)、下丘脑外侧区(LH)、下丘脑腹内侧区和下丘脑后区(PH)更为明显。然而,向内侧隔核内注射 DAMGO 对 T(b)几乎没有影响。这些结果表明,在冬眠维持阶段,ARC 神经元合成的 β-内啡肽通过激活 PO、AH、VMH、DMH 和 PH 中的 μ 阿片受体来调节 T(b)。